Literature DB >> 11001245

Comments on "Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study".

H B Demb, K Roychoudhury.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11001245     DOI: 10.1097/00004714-200010000-00016

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  1 in total

1.  Olanzapine in the treatment of pervasive developmental disorders: a case series analysis.

Authors:  Chrissoula Stavrakaki; Ruxandra Antochi; Patricia C Emery
Journal:  J Psychiatry Neurosci       Date:  2004-01       Impact factor: 6.186

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.